Crossmark

Resistin facilitates breast cancer progression via TLR4-mediated induction of mesenchymal phenotypes and stemness properties

Crossref DOI link: https://doi.org/10.1038/onc.2017.357

Published Online: 2017-10-09

Published Print: 2018-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wang, C-H

Wang, P-J

Hsieh, Y-C

Lo, S

Lee, Y-C

Chen, Y-C

Tsai, C-H

Chiu, W-C

Chu-Sung Hu, S

Lu, C-W

Yang, Y-F

Chiu, C-C

Ou-Yang, F

Wang, Y-M

Hou, M-F

Yuan, S-SF
License Information

Text and Data Mining valid from 2017-10-09
More Information

Article History

Received: 15 December 2016

Revised: 6 July 2017

Accepted: 6 July 2017

First Online: 9 October 2017

Competing interests

: The authors declare no conflict of interest.